7th Summit on Biosimilars and Follow-On Biologics

Washington, DC — www.cbinet.com

Analyze the Regulatory Landscape, Market Competition and Clinical Process to Maximize Commercial Potential

Position Yourself for Commercial Success in the Evolving Biosimilars Landscape

With new FDA guidelines on the horizon concerning the development of biosimilars, understanding the regulatory and commercial realities of the biologics market is more important than ever. Our summit places unique focus on the assessment of market access, strategies for effective commercialization and options for interchangeability.  Join us to explore the current climate for biosimilars business including evaluation of the competitive landscape, reimbursement considerations and patient safety.

This interactive forum covers :

• Examining user fee requirements to prepare a biosimilar application
• Analyzing Europe’s role in biosimilar development
• Determining the appropriate pricing scheme for biosimilars
• Ensuring appropriate nomenclature and labeling of biosimilars
• Comparing the challenges of interchangeable vs. similar biologics